Sound waves aim to soothe stubborn heel pain
NCT ID NCT06697834
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This trial investigates whether histotripsy, a focused ultrasound technique, can reduce pain in people with plantar fasciitis that has not responded to standard treatments like shock waves, orthotics, or steroid injections. Participants receive two ultrasound sessions and report their pain levels over 75 days. The goal is to see if this non-invasive approach offers relief for chronic heel pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- histotripsy ultrasound session
- What this could lead to
- If it works, this could offer a new, non-invasive option for managing chronic heel pain when other treatments have failed.
- What could go wrong
- This is a small, early study with no comparison group, so results may not be conclusive. Histotripsy is still experimental for this condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
31 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient, male or female, aged 18 years minimum * Patient with plantar fasciitis evolving for at least 6 months * Patients with radiology and MRI of the foot less than 3 months old * Visual analogue pain scale greater than 5 at inclusion * Patient in whom conventional medical treatment has failed by the combination of radial shock waves, plantar orthoses, and corticosteroid infiltration that has not provided relief. * Patient affiliated with or beneficiary of a social security scheme. * Patient who has been informed and has given his/her free, informed and written consent. Exclusion Criteria: * Minor patient * Major retraction of the triceps surae on the MAESTRO oblique board test: sequelae of bone trauma to the hindfoot and ankle. * Inflammatory rheumatological diseases * Fibromyalgia * Patients in whom a specific underlying organic pathology (inflammatory, infectious, neoplastic, etc.) has been identified. * Psychiatric disorders * Patient participating in another research study. * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient woman. * Patient hospitalized without consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aponeurosis contusion are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinique de Domont
Domont, 95330, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.